Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (221-230 of 470) with videos related to

Pageof 47
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 12, 2019
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's DiseaseNathan Herrmann, Myuri Ruthirakuhan, Damien Gallagher, et al.
Stroke|August 14, 2019
Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic AttackArunima Kapoor, Kevin Si, Amy Y X Yu, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery diseaseWalter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Archives of General Psychiatry|November 9, 2005
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probeLescia K Tremblay, Claudio A Naranjo, Simon J Graham, et al.
Cardiovascular Psychiatry and Neurology|December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease PatientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 12, 2007
Sharing the responsibility for assessing the risk of the driver with dementiaMark J Rapoport, Nathan Herrmann, Frank J Molnar, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injuryMark J Rapoport, Robert A Mitchell, Scott McCullagh, et al.
Neuroscience and Biobehavioral Reviews|April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorderWalter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Brain, Behavior, and Immunity|October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology|August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialGraham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Pageof 47

Showing results (221-230 of 470) with videos related to

Sort By:
Pageof 47
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 12, 2019
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's DiseaseNathan Herrmann, Myuri Ruthirakuhan, Damien Gallagher, et al.
Stroke|August 14, 2019
Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic AttackArunima Kapoor, Kevin Si, Amy Y X Yu, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery diseaseWalter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Archives of General Psychiatry|November 9, 2005
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probeLescia K Tremblay, Claudio A Naranjo, Simon J Graham, et al.
Cardiovascular Psychiatry and Neurology|December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease PatientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 12, 2007
Sharing the responsibility for assessing the risk of the driver with dementiaMark J Rapoport, Nathan Herrmann, Frank J Molnar, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injuryMark J Rapoport, Robert A Mitchell, Scott McCullagh, et al.
Neuroscience and Biobehavioral Reviews|April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorderWalter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.
Brain, Behavior, and Immunity|October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology|August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialGraham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Pageof 47